Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nkarta, Inc. | Chief Medical Officer | Common Stock | 12.8K | $112K | $8.74 | Jan 14, 2022 | Direct |
Senti Biosciences, Inc. | Chief Medical & Devt. Officer | Stock Option (Right to Buy) | 152K | Feb 1, 2024 | Direct | ||
Senti Biosciences, Inc. | Chief Medical & Devt. Officer | Common Stock | 101K | Feb 1, 2024 | Direct | ||
Nkarta, Inc. | Chief Medical Officer | Stock Option (right to buy) | 76.8K | Jan 14, 2022 | Direct | ||
Turnstone Biologics Corp. | Director | Stock Option (Right to Buy) | 12.8K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TSBX | Turnstone Biologics Corp. | Jun 3, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
SNTI | Senti Biosciences, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 2, 2024 | Chief Medical & Devt. Officer |
TSBX | Turnstone Biologics Corp. | Oct 16, 2023 | 1 | $0 | 4 | Oct 17, 2023 | Director |
TSBX | Turnstone Biologics Corp. | Jul 20, 2023 | 0 | $0 | 3 | Jul 20, 2023 | Director |
SNTI | Senti Biosciences, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 2, 2023 | Chief Medical & Devt. Officer |
SNTI | Senti Biosciences, Inc. | Jul 18, 2022 | 1 | $0 | 4 | Jul 20, 2022 | Chief Medical & Devt. Officer |
SNTI | Senti Biosciences, Inc. | Jul 5, 2022 | 0 | $0 | 3 | Jul 15, 2022 | Chief Medical & Devt. Officer |
NKTX | Nkarta, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 19, 2022 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Aug 5, 2021 | 3 | -$369K | 4 | Aug 9, 2021 | Chief Medical Officer |